CFG
ABBV icon

Citizens Financial Group’s AbbVie ABBV Stock Holding History

Citizens Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.1M Sell
170,368
-4,753
-3% -$1.05M 0.52% 40
2025
Q4 		$40M Sell
175,121
-399
-0.2% -$90.9K 0.54% 38
2025
Q3 		$40.6M Buy
175,520
+20,836
+13% +$4.24M 0.56% 37
2025
Q2 		$28.7M Buy
154,684
+44,068
+40% +$8.19M 0.46% 43
2025
Q1 		$23.2M Sell
110,616
-2,154
-2% -$419K 0.46% 49
2024
Q4 		$20M Buy
112,770
+13,542
+14% +$2.49M 0.39% 59
2024
Q3 		$19.6M Buy
99,228
+4,074
+4% +$760K 0.39% 54
2024
Q2 		$16.3M Buy
95,154
+70,484
+286% +$11.7M 0.36% 59
2024
Q1 		$4.49M Sell
24,670
-3,629
-13% -$625K 0.15% 107
2023
Q4 		$4.39M Buy
28,299
+8,689
+44% +$1.27M 0.15% 116
2023
Q3 		$2.92M Sell
19,610
-1,970
-9% -$289K 0.12% 120
2023
Q2 		$2.91M Sell
21,580
-337
-2% -$49.4K 0.11% 140
2023
Q1 		$3.49M Buy
21,917
+5,071
+30% +$775K 0.13% 126
2022
Q4 		$2.72M Buy
16,846
+450
+3% +$69K 0.11% 127
2022
Q3 		$2.2M Sell
16,396
-1,453
-8% -$209K 0.1% 137
2022
Q2 		$2.73M Sell
17,849
-936
-5% -$143K 0.11% 125
2022
Q1 		$3.04M Buy
18,785
+1,299
+7% +$189K 0.11% 125
2021
Q4 		$2.37M Sell
17,486
-3,347
-16% -$395K 0.08% 145
2021
Q3 		$2.25M Sell
20,833
-12,101
-37% -$1.38M 0.08% 145
2021
Q2 		$3.71M Buy
32,934
+15,944
+94% +$1.8M 0.16% 105
2021
Q1 		$1.84M Buy
16,990
+1,324
+8% +$142K 0.1% 129
2020
Q4 		$1.68M Sell
15,666
-2,051
-12% -$197K 0.1% 132
2020
Q3 		$1.55M Sell
17,717
-14,984
-46% -$1.41M 0.1% 124
2020
Q2 		$3.21M Buy
32,701
+239
+0.7% +$21K 0.23% 95
2020
Q1 		$2.47M Buy
32,462
+14,464
+80% +$1.23M 0.2% 95
2019
Q4 		$1.59M Buy
17,998
+2,866
+19% +$238K 0.11% 123
2019
Q3 		$1.15M Sell
15,132
-4,808
-24% -$330K 0.08% 122
2019
Q2 		$1.45M Sell
19,940
-2,938
-13% -$231K 0.11% 114
2019
Q1 		$1.84M Sell
22,878
-290
-1% -$23.7K 0.14% 110
2018
Q4 		$2.14M Sell
23,168
-83
-0.4% -$7.3K 0.19% 93
2018
Q3 		$2.2M Sell
23,251
-891
-4% -$84.5K 0.17% 98
2018
Q2 		$2.24M Sell
24,142
-2,263
-9% -$221K 0.19% 96
2018
Q1 		$2.5M Sell
26,405
-2,859
-10% -$314K 0.21% 93
2017
Q4 		$2.83M Sell
29,264
-1,402
-5% -$132K 0.23% 85
2017
Q3 		$2.73M Sell
30,666
-9,346
-23% -$711K 0.23% 91
2017
Q2 		$2.9M Sell
40,012
-5,027
-11% -$338K 0.26% 90
2017
Q1 		$2.93M Sell
45,039
-6,454
-13% -$406K 0.26% 88
2016
Q4 		$3.23M Sell
51,493
-2,084
-4% -$127K 0.31% 84
2016
Q3 		$3.38M Sell
53,577
-3,318
-6% -$215K 0.32% 82
2016
Q2 		$3.52M Sell
56,895
-6,345
-10% -$387K 0.34% 79
2016
Q1 		$3.61M Buy
63,240
+22,305
+54% +$1.24M 0.35% 81
2015
Q4 		$2.56M Buy
+40,935
New +$2.36M 0.24% 87

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citizens Financial Group's ABBV Position: Q1 2026 in Review

Citizens Financial Group reduced its AbbVie (ABBV) stake by 2.7% in Q1 2026, selling an estimated $1.05M and leaving 170,368 shares worth $37.1M. The position accounts for 0.52% of the portfolio, ranked #40.

Citizens Financial Group first reported a position in ABBV in Q4 2015 and has held it in 42 quarters since. The position peaked at $40.6M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Citizens Financial Group held 170,368 shares of AbbVie worth $37.1M as of Q1 2026.
  • Citizens Financial Group sold 4,753 AbbVie shares in Q1 2026, an estimated $1.05M.
  • AbbVie made up 0.52% of Citizens Financial Group's portfolio in Q1 2026, its #40 holding.
  • Citizens Financial Group first reported a position in AbbVie in Q4 2015 and has held it in 42 quarters since.
  • Citizens Financial Group's AbbVie position peaked at $40.6M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.